Search clinical trials for: 90Yttrium-Ibritumomab Tiuxetan (Zevalin®) Rituximab
Total 82 results
-
Soroka University Medical CenterUnknown
-
Chulalongkorn UniversityBayerTerminatedDiffuse Large B-cell LymphomaThailand
-
Charite University, Berlin, GermanyUnknownFollicular Lymphoma
-
M.D. Anderson Cancer CenterBiogenCompletedLymphoma, Mantle-CellUnited States
-
University of Wisconsin, MadisonGenentech, Inc.Terminated
-
BiogenCompletedLymphoma, Non-Hodgkin | Lymphoma, Low-GradeUnited States
-
BayerCompletedNon-Hodgkin's Lymphoma (NHL)Japan
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Waldenström Macroglobulinemia | Post-transplant Lymphoproliferative Disorder | Stage III Adult Burkitt Lymphoma | Stage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Burkitt Lymphoma | Stage IV Adult Diffuse...United States
-
Spectrum Pharmaceuticals, IncBayerCompleted
-
BayerCompletedLymphoma, Follicular | Non-Hodgkin LymphomaBelgium
-
Case Comprehensive Cancer CenterTerminatedPrimary Central Nervous System Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterBiogen; CTI BioPharmaCompleted
-
University Hospital, BordeauxBayerCompletedDiffuse Large B-Cell Lymphoma | Mantle Cell LymphomaFrance
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminatedNon-Hodgkin's Lymphoma (NHL)United States
-
M.D. Anderson Cancer CenterBiogenTerminatedLymphomaUnited States
-
Spectrum Pharmaceuticals, IncBayerTerminatedLymphoma, Large Cell, DiffuseSweden, United States, Italy, Korea, Republic of, Spain, United Kingdom, Hungary, Poland, Finland, Canada, France, Germany, Portugal, Thailand, Belgium, Austria, Ireland, Singapore, Switzerland
-
Sheba Medical CenterCity of Hope Medical Center; Amsterdam UMC, location VUmc; University of GöttingenCompletedNon-Hodgkin's LymphomaUnited States, Netherlands, Germany, Israel
-
McGill UniversityMcGill University Health Centre/Research Institute of the McGill University...Unknown
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone... and other conditionsUnited States
-
Chonnam National University HospitalChonbuk National University Hospital; Samsung Medical Center; Pusan National... and other collaboratorsCompletedLymphoma, Large B-Cell, DiffuseKorea, Republic of
-
Institut fuer anwendungsorientierte Forschung und...CompletedPrimary Non-Hodgkin-Lymphoma | Refractory Non-Hodgkin-Lymphoma | CD20+ Aggressive Non-Hodgkin's LymphomaGermany
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
BiogenTerminatedNon-Hodgkin's LymphomaUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell LymphomaUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
BayerCompletedLymphoma, Non-HodgkinBelgium, France, Spain, Italy, Canada, Switzerland, Netherlands, United Kingdom, Portugal, Germany, Sweden, Denmark, Norway
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnn Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedPost-transplant Lymphoproliferative Disorder | Recurrent Childhood Large Cell Lymphoma | Recurrent Childhood Lymphoblastic Lymphoma | Recurrent Childhood Small Noncleaved Cell Lymphoma | Recurrent/Refractory Childhood Hodgkin Lymphoma | AIDS-related Peripheral/Systemic Lymphoma | AIDS-related...United States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Spectrum Pharmaceuticals, IncTerminatedFollicular LymphomaUnited States
-
Spectrum Pharmaceuticals, IncTerminatedDiffuse Large B-cell Lymphoma | Follicle Center LymphomaUnited States, France, United Kingdom, Ireland, Israel, Belgium, Spain, Netherlands, Australia, Puerto Rico, Canada, Italy, Austria
-
The Christie NHS Foundation TrustBayerCompletedFollicular LymphomaUnited Kingdom, France
-
Spectrum Pharmaceuticals, IncTerminated
-
M.D. Anderson Cancer CenterBiogenCompletedLymphoma | Non-Hodgkin's LymphomaUnited States
-
Duke UniversitySpectrum Pharmaceuticals, IncTerminated
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminated
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedLymphomaUnited States
-
AHS Cancer Control AlbertaWithdrawn
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Recurrent... and other conditionsUnited States
-
University of NebraskaBiogenCompleted
-
Beth Israel Deaconess Medical CenterTerminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Terminated
-
Tufts Medical CenterSpectrum Pharmaceuticals, IncTerminatedMultiple MyelomaUnited States
-
University of MiamiCompletedMarginal Zone LymphomaUnited States
-
University of ArizonaNational Cancer Institute (NCI)Completed
-
Oslo University HospitalCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI); BiogenCompletedLymphomaUnited States